Trial intelligence / Profile preview

68Ga-P16-093 PET/CT in Glioma

NCT05569434Phase 2Unknown

Sponsor
Peking Union Medical College Hospital
Start
Nov 2021
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of 68Ga-P16-093 in glioma, sponsored by Peking Union Medical College Hospital. Status: unknown.

02

Drugs

68Ga-P16-093
03

Conditions

glioma

Beyond the preview

Go deeper on NCT05569434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05569434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call